14 results
·
8ms
·
Sources: EU EUDAMED, US FDA
Ustekinumab ELISA
Device
EU IVDR
·
Eu Ivd Class B
·Advanced Practical Diagnostics·On the market·4 countries
Vedolizumab ELISA
Device
EU IVDR
·
Eu Ivd Class B
·Advanced Practical Diagnostics·On the market·4 countries
Golimumab ELISA
Device
EU IVDR
·
Eu Ivd Class B
·Advanced Practical Diagnostics·On the market·4 countries
Anti-Adalimumab ELISA
Device
EU IVDR
·
Eu Ivd Class B
·Advanced Practical Diagnostics·On the market·4 countries
Adalimumab ELISA
Device
EU IVDR
·
Eu Ivd Class B
·Advanced Practical Diagnostics·On the market·4 countries
Anti-Infliximab ELISA
Device
EU IVDR
·
Eu Ivd Class B
·Advanced Practical Diagnostics·On the market·4 countries
Infliximab ELISA
Device
EU IVDR
·
Eu Ivd Class B
·Advanced Practical Diagnostics·On the market·4 countries
Ustekinumab ELISA
Basic UDI-DI
EU IVDR
·
Eu Ivd Class B
·Advanced Practical Diagnostics·1 device
Vedolizumab ELISA
Basic UDI-DI
EU IVDR
·
Eu Ivd Class B
·Advanced Practical Diagnostics·1 device
Golimumab ELISA
Basic UDI-DI
EU IVDR
·
Eu Ivd Class B
·Advanced Practical Diagnostics·1 device
Anti-Adalimumab ELISA
Basic UDI-DI
EU IVDR
·
Eu Ivd Class B
·Advanced Practical Diagnostics·1 device
Adalimumab ELISA
Basic UDI-DI
EU IVDR
·
Eu Ivd Class B
·Advanced Practical Diagnostics·1 device
Anti-Infliximab ELISA
Basic UDI-DI
EU IVDR
·
Eu Ivd Class B
·Advanced Practical Diagnostics·1 device
Infliximab ELISA
Basic UDI-DI
EU IVDR
·
Eu Ivd Class B
·Advanced Practical Diagnostics·1 device